Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in Interest ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Non-cash Items (2016 - 2025)

Marker Therapeutics (MRKR) has disclosed Non-cash Items for 11 consecutive years, with $461202.0 as the latest value for Q4 2025.

  • Quarterly Non-cash Items rose 22.09% to $461202.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $461202.0 through Dec 2025, up 22.09% year-over-year, with the annual reading at $461202.0 for FY2025, 22.09% up from the prior year.
  • Non-cash Items for Q4 2025 was $461202.0 at Marker Therapeutics, up from $438919.0 in the prior quarter.
  • The five-year high for Non-cash Items was $5.9 million in Q3 2022, with the low at $11000.0 in Q2 2025.
  • Average Non-cash Items over 5 years is $1.8 million, with a median of $662167.5 recorded in 2023.
  • The sharpest move saw Non-cash Items soared 1340.94% in 2022, then crashed 99.08% in 2025.
  • Over 5 years, Non-cash Items stood at $4.3 million in 2021, then tumbled by 86.95% to $560929.0 in 2022, then soared by 134.83% to $1.3 million in 2023, then plummeted by 71.32% to $377767.0 in 2024, then increased by 22.09% to $461202.0 in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $461202.0, $438919.0, and $11000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.